Evaluation of the effect of injectable dexamethasone on excretion of distal ureteral stones

Evaluation of the effect of injectable dexamethasone on the frequency and excretion time of distal ureteral stones

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N59

Enrollment

100

Registered

2022-09-12

Start date

2022-09-21

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of ureter. Calculus of ureter

Interventions

Intervention 1: Intervention group: Patients in this group are treated orally with Tamsulosin 0.4 mg / day for two weeks. In addition, an intramuscular injection of 8 mg dexamethasone will be given. I

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definitive diagnosis of distal ureteral stones below 1 cm Age over 18 years Indicated for drug therapy Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Having benign prostatic hyperplasia (BPH) at the same time Having a narrowing of the urethra Contraindications to the use of corticosteroids Existence of hydronephrosis

Design outcomes

Primary

Measure	Time frame
Frequent distal ureteral stone excretion. Timepoint: Until the end of two weeks of intervention. Method of measurement: Observational.;Time to excrete distal ureteral stone. Timepoint: Until the end of two weeks of intervention. Method of measurement: Observational.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Kazemi

Esfahan University of Medical Sciences

dr.rezakazemi6788@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026